Molecular characteristics and infection rates in patients with gastric cancer in Western Poland: a comparative analysis of gastrectomy specimens across two decades.
1/5 보강
[INTRODUCTION] Gastric cancer incidence and characteristics vary due to environmental factors, and technical advances facilitate early detection of the disease.
APA
Majewski J, Moszyńska M, et al. (2026). Molecular characteristics and infection rates in patients with gastric cancer in Western Poland: a comparative analysis of gastrectomy specimens across two decades.. Frontiers in oncology, 16, 1651941. https://doi.org/10.3389/fonc.2026.1651941
MLA
Majewski J, et al.. "Molecular characteristics and infection rates in patients with gastric cancer in Western Poland: a comparative analysis of gastrectomy specimens across two decades.." Frontiers in oncology, vol. 16, 2026, pp. 1651941.
PMID
41710671 ↗
Abstract 한글 요약
[INTRODUCTION] Gastric cancer incidence and characteristics vary due to environmental factors, and technical advances facilitate early detection of the disease. This study aimed to assess whether significant socio-economic changes and technological advancements in Poland - one of the most rapidly developing countries worldwide - affected the molecular characteristics and detection rates of early gastric cancer sub-types in Western Poland.
[METHODS] Ninety-two patients undergoing gastrectomy for gastric cancer in 1998-2002 and 2016-2020 were studied. Surgical specimens were re-analyzed for histopathological features, including tumor type, grade, and stage (up-dated World Health Organization [WHO] classification). Immunohistochemical markers (Ki-67, p53, E-cadherin, CD10, CD31, bcl-2) and antigens for Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV) were evaluated. Microsatellite instability (MSI) was assessed via PMS2/MSH2 protein expression.
[RESULTS] The groups were comparable in age and gender, with male predominance. Histological features, H. pylori and EBV colonization, and most molecular markers showed no significant differences. However, Ki-67 proliferation index significantly increased in cancers diagnosed in 2016-2020, correlating with intestinal-type tumors and p53 expression. In this group, higher Ki-67 levels were also linked to H. pylori infection, microsatellite stability, and increased angiogenesis.
[CONCLUSIONS] Despite advancements in H. pylori research and technology over 20 years, no improvement was observed in H. pylori-positive tumor rates or early gastric cancer detection in Western Poland. Although molecular characteristics remained largely unchanged, the increased proliferation index in recently diagnosed cancers merits further study.
[METHODS] Ninety-two patients undergoing gastrectomy for gastric cancer in 1998-2002 and 2016-2020 were studied. Surgical specimens were re-analyzed for histopathological features, including tumor type, grade, and stage (up-dated World Health Organization [WHO] classification). Immunohistochemical markers (Ki-67, p53, E-cadherin, CD10, CD31, bcl-2) and antigens for Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV) were evaluated. Microsatellite instability (MSI) was assessed via PMS2/MSH2 protein expression.
[RESULTS] The groups were comparable in age and gender, with male predominance. Histological features, H. pylori and EBV colonization, and most molecular markers showed no significant differences. However, Ki-67 proliferation index significantly increased in cancers diagnosed in 2016-2020, correlating with intestinal-type tumors and p53 expression. In this group, higher Ki-67 levels were also linked to H. pylori infection, microsatellite stability, and increased angiogenesis.
[CONCLUSIONS] Despite advancements in H. pylori research and technology over 20 years, no improvement was observed in H. pylori-positive tumor rates or early gastric cancer detection in Western Poland. Although molecular characteristics remained largely unchanged, the increased proliferation index in recently diagnosed cancers merits further study.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.
- Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.
- Correction: Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012-2023).